ITPP
ITPP specializes in project management, consulting, advice and training services for management and organizational development.
ITPP
Social Links:
Industry:
Advice Consulting Project Management
Founded:
1997-01-01
Address:
Lysaker, Akershus, Norway
Country:
Norway
Website Url:
http://www.itpp.no
Total Employee:
11+
Status:
Active
Contact:
47-95-79 03 42
Email Addresses:
[email protected]
Technology used in webpage:
IPv6 Domeneshop
Similar Organizations
FitzMe
FitzMe offers online vitality, lifestyle, advice, project management, and research services for people and organizations.
INoTHINGS
INoTHINGS offers project management, consulting, design, and implementation in the areas of networks, system technology, and cloud services.
pmwares
pmwares is project management consulting company that provides training and advisory services for managing projects.
Official Site Inspections
http://www.itpp.no
- Host name: bristol.domeneshop.no
- IP address: 194.63.248.52
- Location: Norway
- Latitude: 59.9452
- Longitude: 10.7559
- Timezone: Europe/Oslo
More informations about "ITPP"
NATO - Official text: Individually Tailored Partnership Programme ...
Jul 20, 2023 Today, Japan and the North Atlantic Treaty Organization (NATO) stand together as like-minded partners in an increasingly complex global and regional security environment. …See details»
Thrombotic Thrombocytopenic Purpura
Nov 29, 2023 Find A Rare Disease Organization; Stay informed. ... There is an acquired (non-inherited) form of TTP referred to as immune-mediated TTP (iTTP) and a familial form referred …See details»
Japan, NATO to Sign New Agreement, Strengthen …
Jul 10, 2023 Japan will formulate a new agreement to strengthen cooperation with the North Atlantic Treaty Organization with the aim of dealing with such risks as disinformation and the military use of space, according to government …See details»
Treatment of immune-mediated thrombotic thrombocytopenic …
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is an autoimmune thrombotic microangiopathy caused by inhibitory autoantibodies against the von Willebrand factor (VWF) …See details»
What is CABLIVI? - CABLIVI (caplacizumab-yhdp) …
A global organization of experts recommends using CABLIVI, plasma exchange, and immunosuppression based on lab testing and diagnosis. CABLIVI, in combination with PEX and immunosuppression, is the only FDA-approved …See details»
ITPP - UNIDO ITPO Germany
Investment and Technology Promotion Platform (ITPP) Access Online Platform ITPO Germany’s global project database for innovative business opportunities and technologies that accelerate sustainable industrial development. The …See details»
Frontiers | Immune-Mediated Thrombotic …
May 16, 2022 Introduction. An increasing number of case reports have associated vaccinations against coronavirus disease 2019 (COVID-19) with immune-mediated thrombotic thrombocytopenic purpura (iTTP), a very rare …See details»
Management of immune thrombotic thrombocytopenic purpura …
Oct 3, 2024 The main outcome was the time to platelet count normalization. Secondary outcomes included clinical response, exacerbation, refractory iTTP, iTTP-related deaths, and …See details»
Management of Immune Thrombotic Thrombocytopenic Purpura …
Dec 11, 2023 Caplacizumab, an anti-VWF nanobody, is approved for iTTP treatment, reducing the need for therapeutic plasma exchange (TPE) and improving platelet count recovery and …See details»
How I treat immune-mediated thrombotic …
Aug 4, 2022 At least 2 studies have demonstrated a shorter life expectancy in survivors of an acute iTTP episode, with cardiovascular complications playing a significant role. 1,43 Published work by Upreti et al demonstrated a fivefold …See details»
Recent advances in the management of immune-mediated …
‘Refractory iTTP’ is defined as a lack of platelet count increment (platelet count <50×10 9 /L) with persistently high LDH levels (>1.5×ULN) despite undergoing PEX five times or a decrease in …See details»
Relapse of immune-mediated thrombotic thrombocytopenic …
Immune-mediated thrombotic thrombocytopenic purpura (iTTP), a rare and life-threatening disease with an annual incidence of roughly 1.5 new cases/million, is characterized by …See details»
Management of Immune Thrombotic Thrombocytopenic Purpura …
Nov 2, 2023 The median time to platelet count normalization was similar between the two cohorts (3 and 4 days; P = 0.31, see Figure 1). There were no significant differences in clinical …See details»
Outcomes and Costs in Patients with Immune Thrombotic …
Mar 24, 2024 Acquired thrombotic thrombocytopenic purpura, also known as immune-mediated thrombotic thrombocytopenic purpura (iTTP), is a rare, life-threatening, immune-mediated …See details»
Management of immune thrombotic thrombocytopenic purpura …
Oct 3, 2024 Immune thrombotic thrombocytopenic purpura (iTTP) is an ultrarare, acute, and life-threatening autoimmune disease. Therapeutic plasma exchange (TPE), along with steroids …See details»
Thrombotic Thrombocytopenic Purpura: Pathophysiology, …
Glucocorticoids: steroids are widely used in conjunction with TPE at the initiation of therapy for acute iTTP. Though there are no randomized clinical trials comparing TPE with steroids vs. …See details»
Transfer of ADAMTS13 antibody-mediated thrombotic
ADAMTS13 opening in iTTP is hypothesized to be initiated by a still unknown trigger and then enhanced by ADAMTS13 antibodies produced after exposure of a cryptic site.8 7 Interestingly, …See details»
Incidence, diagnosis, and outcome of immune-mediated
Fifteen patients (7.4%) died as a direct consequence of iTTP, 6 of them before receiving any iTTP-specific treatment. Thirty-one (16.1%) of the 193 treated episodes were refractory to …See details»
The standard of care for immune thrombotic thrombocytopenic …
Targeted therapy of immune thrombotic thrombocytopenic purpura (iTTP) requires acurate and prompt diagnosis and differentiation from complement‐mediated hemolytic uremic syndrome …See details»
(PDF) Thrombotic Thrombocytopenic Purpura: A Narrative Review …
Apr 30, 2021 treatment for all iTTP patients typically oral predni solone at t he above dose and we comm ence weaning when the patient has successfully ceased PEX , and ADAMTS13 …See details»